Table 2 Change of variables after 12 weeks of treatment
Variables | Placebo (N=20) | Carnosine (N=20) | P value |
|---|---|---|---|
Body weight (kg) | -0.65±1.64 | -0.22±2.23 | 0.167 |
Body mass index (kg/m2) | -0.25±0.65 | -0.18±0.97 | 0.101 |
Systolic blood pressure (mmHg) | -0.90±7.38 | -3.15±12.40 | 0.217 |
Diastolic blood pressure (mmHg) | -1.95±6.20 | 0.35±6.32 | 0.424 |
BUN (mg/dL) | 1.76±5.23 | 0.48±5.59 | 0.199 |
Creatinine (mg/dL) | 0.01±0.11 | -0.03±0.13 | 0.523 |
GFR (mL/min/1.73m2) | -0.29±8.04 | 4.18±11.82 | 0.232 |
Fasting plasma glucose (mg/dL) | -25.9 ± 73.6 | -16.7 ± 73.59 | 0.696 |
HemoglobinA1C (%) | -0.07±1.46 | -0.33±0.78 | 0.486 |
LDL (mg/dL) | 10.30±47.40 | -23.40±86.60 | 0.556 |
HDL (mg/dL) | 1.60±12.10 | -1.90±11.0 | 0.929 |
Cholesterol (mg/dL) | 9.84±51.90 | -10.10±41.60 | 0.984 |
Triglyceride (mg/dL) | -9.20±70.70 | -0.50±63.70 | 0.653 |